Pulmonary resistance is elevated early in preterm infants who later develop chronic lung
disease. This early increase in pulmonary resistance may play a role in the development of …

The effects of isoproterenol inhalation on pulmonary mechanics in ten infants with
bronchopulmonary dysplasia (BPD), aged 41±1 (SE) weeks postconception, with …

The response to nebulized therapy was studied at a median postnatal age of 16 months
(range 6–24 months) in 15 children born prematurely. Thoracic gas volume (TGV) and …

Albuterol is a specific beta‐2 agonist that has been reported to be effective in treating infants
and children with bronchospastic pulmonary disease. The use of oral albuterol has not been …

We hypothesized that infants recovering from severe bronchopulmonary dysplasia have
airway constriction that is, at least in part, related to borderline hypoxia. If this hypothesis …

Bronchodilators are often used in the treatment of patients with bronchopulmonary dysplasia
(BPD). However, few studies evaluate their efficacy in patients with stable disease beyond …

We evaluated bronchial lability and responsiveness in 29 prematurely born children (birth
weight< 1,250 g) 8 to 14 yr of age, 12 with histories of bronchopulmonary dysplasia (BPD) …

Using a noninvasive passive flow volume technique to measure respiratory system
resistance (Rrs) and compliance (Crs), the effects of two inhaled bronchodilators, salbutamol …

We compared the effect of salbutamol and placebo in a double-blind study of preterm infants
with bronchopulmonary dysplasia, using a randomized, cross-over design with several …

The main purpose of this study was to evaluate four different forms of treatment in young
infants admitted for acute wheezing (AW). Seventy‐nine infants less than one year of age …